C

디오

039840KOSDAQ의료용 기기 제조업

44.8 / 100

Reference Date: 2026-06-10

Financial Score13.5 / 40
News Sentiment18.3 / 25
Momentum3.0 / 20
Disclosure10.0 / 15
AI Analysis: PBR is significantly undervalued vs. peers but ROE is below the industry average. Plunged 19.3% over the past month, and news sentiment is positive.

Company InformationBased on 2025 Annual Report

Business Overview

DIO is a medical device company specializing in the manufacturing and sales of dental implants and dental equipment, with key products including the DIO IMPLANT SYSTEM and DIONavi. It generates 87% of its revenue from exports and 13% from domestic sales. The company faces rising titanium raw material costs and operates at 85% of its production capacity, while investing 4,143 million won annually in R&D.

Number of Employees

475people

Average Salary

51.2M KRW

Score Calculation Basis

Detailed Financial Score

PER
Industry Average 21.514.0Point
PBR
0.93Industry Average 1.385.5Point

Lower than industry avg (good)

ROE
-0.69Industry Average 8.000.0Point

Well below industry avg

Debt Ratio
15.70Industry Average 11.652.0Point

Higher than industry avg (caution)

Trend 2023~20252.0 / 10 points
Revenue Growth Rate
2.0 / 3

Avg ▲7.0% (2-year basis)

Operating Profit Growth Rate
0.0 / 3

Avg ▼85.1% (2-year basis)

ROE Trend
0.0 / 4

Avg ROE -6.7% (declining, 3yr)

Detailed News Sentiment

3 totalPositive 2Neutral 1Negative 0Average Sentiment Score 73.3

Detailed Momentum

52-week position1.0Point

Near 52w low (0%, downtrend)

Current 13,220Won52-week high 19,45052-week low 13,220
1-month return0.0Point

1m -19.29% (strong drop)

Volume trend2.0Point

Volume decreasing

Detailed Disclosure

6 totalPositive 0Neutral 6Negative 0
  • Neutral기업설명회(IR)개최2026-06-04
  • Neutral신탁계약에의한취득상황보고서2026-06-04
  • Neutral임원ㆍ주요주주특정증권등소유상황보고서2026-05-18
  • Neutral자기주식처분결과보고서2026-05-18
  • Neutral임원ㆍ주요주주특정증권등소유상황보고서2026-05-18